These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7732591)

  • 1. Cell-cycle regulators and cancer.
    Kamb A
    Trends Genet; 1995 Apr; 11(4):136-40. PubMed ID: 7732591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
    Maelandsmo GM; Flørenes VA; Hovig E; Oyjord T; Engebraaten O; Holm R; Børresen AL; Fodstad O
    Br J Cancer; 1996 Apr; 73(8):909-16. PubMed ID: 8611425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclin-dependent kinase inhibitory proteins in normal and transformed choroidal melanocytes].
    Mouriaux F; Maurage CA; Labalette P; Casagrande F; Malecaze F; Darbon JM
    J Fr Ophtalmol; 1999 Apr; 22(3):339-46. PubMed ID: 10337591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of a cell cycle regulator in hereditary and sporadic cancer.
    Kamb A
    Cold Spring Harb Symp Quant Biol; 1994; 59():39-47. PubMed ID: 7587092
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor suppression. Lessons in p16 from phylum Falconium.
    Sheaff RJ; Roberts JM
    Curr Biol; 1995 Jan; 5(1):28-31. PubMed ID: 7697342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.
    Hall M; Peters G
    Adv Cancer Res; 1996; 68():67-108. PubMed ID: 8712071
    [No Abstract]   [Full Text] [Related]  

  • 9. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer.
    Musgrove EA; Lilischkis R; Cornish AL; Lee CS; Setlur V; Seshadri R; Sutherland RL
    Int J Cancer; 1995 Nov; 63(4):584-91. PubMed ID: 7591270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B.
    Frost SJ; Simpson DJ; Farrell WE
    Mol Cell Endocrinol; 2001 May; 176(1-2):29-37. PubMed ID: 11369440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle control and cancer.
    Sherr CJ
    Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
    Newton Bishop JA; Harland M; Bennett DC; Bataille V; Goldstein AM; Tucker MA; Ponder BA; Cuzick J; Selby P; Bishop DT
    Br J Cancer; 1999 Apr; 80(1-2):295-300. PubMed ID: 10390011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cell cycle regulator potentially involved in genesis of many tumor types.
    Kamb A; Gruis NA; Weaver-Feldhaus J; Liu Q; Harshman K; Tavtigian SV; Stockert E; Day RS; Johnson BE; Skolnick MH
    Science; 1994 Apr; 264(5157):436-40. PubMed ID: 8153634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle regulators in cancer cell metabolism.
    Leal-Esteban LC; Fajas L
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165715. PubMed ID: 32035102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1.
    Akagi T; Ono H; Shimotohno K
    Oncogene; 1996 Apr; 12(8):1645-52. PubMed ID: 8622884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in molecular mechanisms of leukemogenesis: the cyclin-dependent kinase 4-inhibitor gene in human leukemias.
    Hirai H; Ogawa S; Hangaishi A; Takahashi T; Kurokawa M; Mitani K; Ueda R; Yazaki Y
    Leukemia; 1997 Apr; 11 Suppl 3():358-60. PubMed ID: 9209389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.